Papers

12

Total Citations

129

H-Index

5

About

Dr. Tomoaki Miyagawa is a leading urologic surgeon and researcher whose work centers on advancing robot-assisted surgery for prostate and bladder cancers. His primary contributions lie in refining surgical techniques to improve patient outcomes, particularly through the study of Retzius-sparing robot-assisted radical prostatectomy (RsRARP). His most-cited paper (39 citations) established the learning curve for this approach across three continents, demonstrating its global feasibility. Miyagawa’s research has critically shown that while RsRARP offers superior continence recovery, it carries a higher positive margin rate for anterior tumors—a key insight for surgical planning. He has also investigated the utility of robot-assisted radical cystectomy for muscle-invasive bladder cancer (38 citations) and the role of extended pelvic lymph node dissection in high-risk prostate cancer. Notably, his novel anterior approach to robotic prostatectomy, which spares the Retzius space, has been associated with both lower inguinal hernia rates and earlier continence recovery, representing a significant technical innovation. With over 120 citations across his top works, Miyagawa’s impact is evident in his ability to balance oncologic rigor with functional preservation, making him a pivotal figure in minimally invasive urologic oncology.

Research Focus

Key Achievements

5
H-Index
12
Papers
129
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Retzius‐sparing robot‐assisted radical prostatectomy: early learning curve experience in three continents
39 citations · 2020
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 63
🏛 Institutions: Jichi Medical University, Jichi Medical University Saitama Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago